|
| Home : Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps |
|
Dec 11
2019 |
Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps |
|
EAST HANOVER, N.J., Dec. 11, 2019 /PRNewswire/ -- The submission is based on positive results from the Phase III POLYP 1 and POLYP 2 studies of Xolair in adults with chronic rhinosinusitis with nasal polyps with inadequate response to intranasal corticosteroids If approved, Xolair would... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/novartis-announces-fda-filing-acceptance-of-xolair-omalizumab-for-treatment-of-nasal-polyps-300972831.html |
| |
|
Related News
|
» Beamex apresenta uma revolução em calibração de temperatura
» Saudi pilot used gun loophole to buy murder weapon: FBI
|
|
|
